NIH notice prohibits grant awardees from operating programs that promote DEI

In The Headlines: A good week for NIH, a bad week for Vinay Prasad

While doing somewhat-routine reporting on this year’s Senate Appropriations Committee bills, Paul Goldberg, editor and publisher of The Cancer Letter, quickly realized that he was seeing a full bipartisan rejection of President Donald J. Trump’s plan to defund and therefore dismantle biomedical research in the United States.

August 06, 2025

Vol.51 No.30

Capitol Hill

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

Bits of good news for NIH flickered consistently over the past week.

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

NCI announced that the paylines for R01 grants for established and new investigators are expected to drop to the 4th percentile—a historic low for the institute.

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

A report from the nonpartisan Congressional Budget Office said that proposed cuts at NIH could lead to a decrease in the number of new drugs that come to market in the next three decades.

July 25, 2025

Vol.51 No.29

By Paul Goldberg

Podcast The Directors

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

“I don’t think any good cancer center director would be worth their weight in salt if they weren’t worried about something at night,” said Mark Evers, director of University of Kentucky Markey Cancer Center.

July 18, 2025

Vol.51 No.28

By Paul Goldberg and Katie Goldberg

Cancer Policy

NIH says it’s moving away from animal-based models

NIH has announced that it will no longer be issuing Notices of Funding Opportunities exclusively supporting animal models.

July 18, 2025

Vol.51 No.28

By Claire Marie Porter

NIH notice prohibits grant awardees from operating programs that promote DEI

YOU MAY BE INTERESTED IN

In The Headlines: A good week for NIH, a bad week for Vinay Prasad

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

NIH says it’s moving away from animal-based models

Renew today!

Subscriber content

Never miss an issue!

Login

NIH notice prohibits grant awardees from operating programs that promote DEI

YOU MAY BE INTERESTED IN

In The Headlines: A good week for NIH, a bad week for Vinay Prasad

GOP-led Congress rejects Trump’s plans to gut medical researchSenate bill gives NIH a $400 million raise

FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts

The effects of NIH, FDA cuts will be felt for decades, CBO report estimates

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentumAs oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

NIH says it’s moving away from animal-based models

Never miss an issue!

Login

GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic